IRCT201509064345N5CompletedPhase 2
Protection rule of N-acetyl L-cysteine in improvement of pulmonary condition in chronic obstructive pulmonary disease (COPD) patients after coronary artery bypass grafting (CABG) surgery
Vice chancellor for research of Guilan University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 25 years to 60 years (—)
- Sex
- All
Inclusion Criteria
- •Age 25 to 60 years old;Ejection fraction more than or equal to 40 percent
- •Exclusion criteria :Massive blood transfusion; Any complication caused prolongation of operation or intubation
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Not Applicable
acetylcysteine as a Preventive Measure for Contrast Induced Nephropathy in Intensive Care Patients with Renal InsufficiencyRenal insufficiencyUrological and Genital DiseasesISRCTN43635237Academic Medical Centre (AMC) (Netherlands)246
Completed
Not Applicable
se of N-Acetylcysteine for prevention of Heart-Lung machine associated liver complication in cardiac surgeryCTRI/2018/05/014024Dr Ram Manohar Lohia institute of Medical Sciences Lucknow66
Completed
Not Applicable
Effect of N - Acetylcysteine in the prevention of ototoxicity caused by vancomycin.Peritonitis.Peritonitis, unspecifiedIRCT201202148032N2Research Assistance Of Tabriz University Of Medical Science60
Completed
Not Applicable
The use of perioperative n-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypassCoronary artery bypass graft surgeryCirculatory SystemISRCTN94451985The Physician Services Incorporated Foundation (Canada)295
Recruiting
Phase 3
Prophylactic effect of N-acetyl-cysteine plus Atorvastatin versus N-acetyl-cysteine and Atorvastatin alone for the prevention of contrast induced nephropathyContrast induced nephropathy.Other complications following infusion, transfusion and therapeutic injectionT80.8IRCT20180417039347N1Zahedan University of Medical Sciences250